Effector-primed TCF1+ CD8+ T cells elicited by a networked epitope vaccine stratify protection against SHIV acquisition
Matthew A. Getz, Aljawharah Alrubayyi, Mariane Melo, Anna K. Traunbauer, Hsinyen Huang, Anusha Nathan, Linette Rodriguez, Shaown Bhattacharyya, Ben Goldberg, Ryan Yim, Sandra Vo, Sabrina Urbancik, Alton Gayton, Ming Tao, Deuk Lim, , Gaurav D. Gaiha
This study identifies an effector-primed TCF1+ CD8+ T cell state linked to delayed SHIV acquisition and reduced viral load in vaccinated non-human primates.
bioRxiv · Oct 25, 2026 · PreprintImmunology